Digestive System Diseases  >>  Recombivax HB (hepatitis B vaccine recombinant)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD)
NCT02055365: Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

Completed
N/A
10
US
Hepatitis B Vaccine (Recombinant), Recombivax HB - Merck & Co., Inc.
Rockefeller University
Hepatitis B
01/15
01/15

Download Options